Patent of Crestor expires on Apr 11, so authentic subsequent drugs are pouring into the market
Today (Apr 11), as patent of hyperlipidemia treatment Crestor (Rosuvastatin) expires, subsequent drug competition begins.
On Apr 11, according to the related industry, patent of Crestor expires, so authentic subsequent drugs pour. The number of generic drugs which completed registration in the i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
